Clinical Trials Curriculum

Activity Description

This series of e-Learning modules will cover general methodology and processes for conducting clinical trials.

This series is supported by AstraZeneca.

Target Audience

Trainees, early-career surgeons, and community-based surgeons.

Learning Objectives


Upon completing Getting Started With Study Design, participants should be able to:

  • Differentiate between the different types of study design methodologies.
  • Distinguish between industry and investigator-initiated trials.
  • Identify and describe the different phases of trials.
  • Highlight the importance of cross-disciplinary collaboration.
     

Upon completing Funding, participants should be able to:

  • Differentiate between the different types of grants.
  • Understand the application process to apply for a federal grant.
  • Highlight the importance of a protocol budget.

Upon completing Study Outcomes, participants should be able to:

  • Differentiate pathologic endpoints measured by clinical trials.
  • Translate between oncologic and survival outcomes.
  • Identify the use of biomarkers in clinical trial design.
Activity summary
Activity opens: 
12/25/2022
Activity expires: 
12/31/2025
Cost:
$0.00

Unless otherwise noted, the faculty for this activity have nothing to disclose.

Loretta Erhunmwunsee, MD, FACS
City of Hope, Pasadena, CA

Onkar V. Khullar MD, MSc, FACS
Emory University, Atlanta, GA

Lye-Yeng Wong, MD
Stanford University, Stanford, CA

Natalie S. Lui, MD
Stanford University, Stanford, CA

Price

Cost:
$0.00
Please login or register to take this course.

 

E-Learning Modules are set to open in a new browser window.  

Once you have entered this activity, you will be reminded to enable pop-ups in your browser settings for desktop, mobile, and tablet devices.  

The module will register as complete once all items, including a post-test, are marked complete.